Standigm and Ajou university medical center sign MOU for an AI-driven clinical drug development


Standigm, Inc. and Ajou university medical center today have signed a Memorandum of Understanding (MOU) for developing drug discovery and improving clinical trials using artificial intelligence technology.

Under the MOU, Aju university medical center will share the CDM (Common Data Model)-based medical information with Standigm. Standigm will develop a new AI-driven platform that improves the clinical trial and drug discovery processes.

Read more in Korean press

Health Chosun,Etnews

Tags: Ajou university medical center , Artificial intelligence , CDM , MOU , Standigm

Categories: News